| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |